Document ID: chunk:federal_register_of_legislation:F2022C01119:front:0:p3
Version: federal_register_of_legislation:F2022C01119
Segment Type: other
Provision Reference: 
Character Range: 6000–9023

connecting gingivitis or death from gingivitis with the circumstances of a person's relevant service:
(1)          being prevented from cleaning the teeth, including toothbrushing and interdental cleansing, for a continuous period of at least 14 days, within the 30 days before the clinical onset of gingivitis;
(2)          having a foreign body embedded in the affected region of the gums at the time of the clinical onset of gingivitis;
Note: Examples of a foreign body embedded in the gums include a fixed orthodontic appliance, an osseointegrated implant or dental prosthesis, particulate materials derived from dental procedures and shrapnel.
(3)          having trauma to the affected region of the gums within the 2 weeks before the clinical onset of gingivitis;
            Note: trauma to the affected region of the gums is defined in the Schedule 1 - Dictionary.
(4)          having direct exposure of the affected area to an irritant substance within the 3 days before the clinical onset of gingivitis;
            Note: irritant substance is defined in the Schedule 1 - Dictionary.
(5)          having direct exposure of the affected area to an allergen within the 3 days before the clinical onset of gingivitis;
            Note: allergen is defined in the Schedule 1 - Dictionary.
(6)          having infection with human immunodeficiency virus at the time of the clinical onset of gingivitis;
(7)          having chronic renal failure at the time of the clinical onset of gingivitis;
            Note: chronic renal failure is defined in the Schedule 1 - Dictionary.
(8)          having leukaemia or lymphoma at the time of the clinical onset of gingivitis;
(9)          taking a drug that causes neutropenia or agranulocytosis, at the time of the clinical onset of gingivitis;
Note: Examples of drugs that cause neutropenia or agranulocytosis include clozapine, sulfasalazine, ticlopidine and thioamides such as methimazole, carbimazole and propylthiouracil.
(10)      having severe vitamin C deficiency at the time of the clinical onset of gingivitis;
            Note: severe vitamin C deficiency is defined in the Schedule 1 - Dictionary.
(11)      having a solid organ transplant, stem cell transplant or bone marrow transplant before the clinical onset of gingivitis;
(12)      being pregnant at the time of the clinical onset of gingivitis;
(13)      using the combined oral contraceptive pill as specified for a continuous period of at least the 4 weeks before the clinical onset of gingivitis;
            Note: combined oral contraceptive pill as specified is defined in the Schedule 1 - Dictionary.
(14)      having an autoimmune or mucocutaneous disease from the specified list of autoimmune or mucocutaneous diseases at the time of the clinical onset of gingivitis;
Note: specified list of autoimmune or mucocutaneous diseases is defined in the Schedule 1 - Dictionary.
(15)      having diabetes mellitus at the time of the clinical onset of gingivitis;
(16)      having infection involving the